Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Postpartum Depression - Pipeline Insight, 2025
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Postpartum Depression: Understanding Postpartum Depression: ... Read More
-
Irritable Bowel Syndrome (IBS) - Market Insight, Epidemiology, and Market Forecast - 2034
... syndrome were reported in the 7MM in 2023. The United States accounted for ~46% of the total 7MM prevalent cases. It has been observed that irritable bowel syndrome is more prevalent in younger ages ( ... Read More
-
Interventional Neurology Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Cerebral Embolization & Aneurysm Coiling, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.0 Billion by ... Read More
-
Intrauterine Devices
... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Asthma Therapeutics
... CAGR of 2.3% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.7 Billion by the end of the analysis ... Read More
-
Cartilage Repair / Cartilage Regeneration
... Billion by 2030, growing at a CAGR of 15.1% over the analysis period 2024-2030. Cell-based Treatment Modality, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$2.3 ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Testing, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More
-
Cognitive Assessment and Training
... 2030, growing at a CAGR of 26.9% over the analysis period 2024-2030. Cognitive Assessment & Training Solutions, one of the segments analyzed in the report, is expected to record a 24.9% CAGR and reach US$17.4 ... Read More
-
Colposcopy
... 3.9% over the analysis period 2024-2030. Optical Instrument, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$580.3 Million by the end of the analysis period. Growth ... Read More
-
Cranial Fixation and Stabilization Systems
... Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Cranial Stabilization Systems, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$987.5 ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Dermatology Devices
... CAGR of 9.5% over the analysis period 2024-2030. Treatment Devices, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$20.5 Billion by the end of the analysis ... Read More
-
Neurovascular Devices / Interventional Neurology
... Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and ... Read More
-
Non-Melanoma Skin Cancer
... at a CAGR of 4.4% over the analysis period 2024-2030. Basal Cell Carcinoma (BCC), one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$835.6 Million by the ... Read More
-
Online Sex Toys
... at a CAGR of 6.8% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.5 Billion by the end of ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 8.3% CAGR ... Read More
-
Nicotine Gum
... CAGR of 4.8% over the analysis period 2024-2030. 2 mg, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$5.0 Billion by the end of the analysis ... Read More
-
Peptic Ulcer Drugs
... at a CAGR of 2.2% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Angina Pectoris Drugs
... at a CAGR of 4.5% over the analysis period 2024-2030. Beta Blockers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.6 Billion by the end of ... Read More
-
Cardiovascular Ultrasound Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. Stress Echocardiogram, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Cervical Total Disc Replacement Devices
... Billion by 2030, growing at a CAGR of 18.3% over the analysis period 2024-2030. Metal-on-BiocompatibleMaterial, one of the segments analyzed in the report, is expected to record a 19.2% CAGR and reach US$9.4 Billion by ... Read More
-
Gastrointestinal Therapeutics
... CAGR of 5.1% over the analysis period 2024-2030. Crohn`s Disease Therapeutics, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion by the end of the ... Read More
-
Gastrointestinal Stents
... CAGR of 5.9% over the analysis period 2024-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of the analysis ... Read More
-
Gastroparesis Drugs
... CAGR of 4.8% over the analysis period 2024-2030. Idiopathic Gastroparesis Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Immuno-Oncology
... 16.2% over the analysis period 2024-2030. Immune Checkpoint Inhibitors, one of the segments analyzed in the report, is expected to record a 16.2% CAGR and reach US$75.1 Billion by the end of the analysis period. ... Read More
Research Assistance
